Acquisition expands Day One’s pipeline with clinical-stage antibody drug conjugate (ADC) emiltatug ledadotin (Emi-Le) targeting rare cancer adenoid cystic carcinoma (ACC) BRISBANE, Calif., Jan. 06, ...
BRISBANE, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (DAWN) (“Day One”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results